What the filings say, before the readout.

Dated flag sheets for Phase 3 biotech names, built from SEC filings, the trial registry and the FDA label index. Each statement cites its document. Calls are scored when the event resolves, and misses stay on the board.

12 sheets 4 calls0 confirmed 0 refuted4 pending

Upcoming readouts

OCGN · Ocugen Inc

readout 2026-09-28 · published 2026-09-02

Stargardt Disease · 13 statements

BHVN · Biohaven Ltd

readout 2026-10-01 · published 2026-09-02

Focal Epilepsy · 8 statements

CLDX · Celldex Therapeutics Inc

readout 2026-10-01 · published 2026-09-02

Chronic Inducible Urticaria · 6 statements

ANNX · Annexon Inc

readout 2026-10-31 · published 2026-09-02

Geographic Atrophy · 7 statements

OLMA · Olema Pharmaceuticals Inc

readout 2026-10-31 · published 2026-09-02

Breast Cancer · 10 statements

SRPT · Sarepta Therapeutics Inc

readout 2026-10-31 · published 2026-09-02

Muscular Dystrophy, Duchenne · 6 statements

CMPX · Compass Therapeutics Inc

readout 2026-12-01 · published 2026-09-02

Biliary Tract Cancer · 9 statements

VIR · Vir Biotechnology Inc

readout 2026-12-01 · published 2026-09-02

Viral Hepatitis · 7 statements

IDYA · Ideaya Biosciences Inc

readout 2027-01-15 · published 2026-09-02

Uveal Melanoma · 8 statements

KOD · Kodiak Sciences Inc

readout 2027-02-01 · published 2026-09-02

Macular Edema Secondary to Inflammation · 7 statements

STOK · Stoke Therapeutics Inc

readout 2027-03-01 · published 2026-09-02

Dravet Syndrome · 7 statements

VOR · Vor Biopharma Inc

readout 2027-05-01 · published 2026-09-02

Primary Sjogren's Disease · 10 statements

Scoreboard

Name	Call	Published	Resolves	Outcome
BHVN	Raises capital within four quarters of 2026-09-02 (runway 1.7q)	2026-09-02	2026-10-01	pending
ANNX	Raises capital within four quarters of 2026-09-02 (runway 3.9q)	2026-09-02	2026-10-31	pending
KOD	Raises capital within four quarters of 2026-09-02 (runway 2.1q)	2026-09-02	2027-02-01	pending
VOR	Raises capital before the 2027-05-01 readout (runway 2.0q)	2026-09-02	2027-05-01	pending

A call is a statement resolved by a future event: that the company raises capital before its registered primary completion, or within four quarters when its runway is that short. A fact is verifiable against its cited document today and is not scored. Sheets are never edited after publication.